| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 12.62 | 0.01 (+0.08%) | 9.71 - 13.09 | 0.0 |
Market data as of 6:05PM 06/18/13. Quotes are delayed by at least 15 min.
The investment seeks capital growth. The fund invests primarily in securities of companies located in at least three developed countries (excluding the United States). Under normal market conditions, the fund's portfolio will primarily consist of securities of companies whose earnings or revenues are not only growing, but growing at an accelerating pace.
| Total Return | 7.35% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.95% |
| Expense Ratio | 1.79% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $2,500 |
| Management Tenure | 10 Years |
| Fund Inception | 08/29/2003 |
| Timeframe | ATGRX | S&P 500 | Foreign Large Growth |
|---|---|---|---|
| 1 Month | -1.89% | 2.34% | -1.28% |
| 3 Month | 3.83% | 8.22% | 2.53% |
| Year-to-Date | 6.86% | 15.37% | 5.27% |
| 1 Year | 30.27% | 27.28% | 23.55% |
| 3 Year | 12.87% | 16.87% | 10.98% |
| 5 Year | -1.00% | 5.43% | -0.65% |
| 10 Year | 7.78% | 7.58% | 8.84% |
| Since Inception | 7.35% | 10.42% | -- |
| Basic Materials | 10.20% | |
|---|---|---|
| Consumer Cyclical | 13.44% | |
| Financial Services | 16.54% | |
| Real Estate | 1.94% | |
| Consumer Defensive | 16.17% | |
| Healthcare | 11.14% | |
| Utilities | 0.02% | |
| Communication Services | 2.04% | |
| Energy | 4.12% | |
| Industrials | 15.11% | |
| Technology | 9.27% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 0.00 | 0.00 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.00 | 0.87 | 0.87 | ||
| Foreign Stock | 0.00 | 99.07 | 99.07 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.00 | 99.94 | 99.94 | ||
| Cash | 0.00 | 0.06 | 0.06 | ||
| Total Net Assets | $1.77B |
|---|---|
| Total Stock Holdings | 122 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Roche Holding AG | 21.67% | 2.39% |
| Unilever PLC | 12.57% | 2.11% |
| Toyota Motor Corp | -- | 2.09% |
| Sanofi | -- | 1.90% |
| Nestle SA | 0.68% | 1.76% |
| Syngenta AG | 36.94% | 1.66% |
| Muenchener Rueckversicherungs AG | -- | 1.60% |
| Novartis AG | 14.18% | 1.50% |
| Orix Corporation | 43.25% | 1.43% |
| Anheuser-Busch Inbev SA | 7.60% | 1.43% |
| Valuation | ATGRX | Category Range |
|---|---|---|
| Price/Earnings | 14.59 | |
| Price/Book | 2.27 | |
| Price/Sales | 1.23 | |
| Price/Cash Flow | 11.30 | |
| Dividend Yield | 1.94 | |
| LT Earnings | 12.6 | |
| Historical Earnings | 12.51 | |
| Sales Growth | -4.57 | |
| Cash-Flow Growth | -4.39 | |
| Book-Value Growth | -14.25 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Above Avg | |
| Return | Above Avg |
| Pretax Return | 12.87% |
|---|---|
| Tax-adjusted Return | 12.70% |
| Tax Cost Ratio | 0.15% |
| Potential Cap Gains | 16.40% |
